Norges Bank’s BridgeBio Pharma BBIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$84.5M Buy
+1,956,654
New +$84.5M 0.01% 766
2025
Q1
Sell
-1,065,479
Closed -$29.2M 188
2024
Q4
$29.2M Buy
+1,065,479
New +$29.2M ﹤0.01% 1154
2024
Q3
Sell
-893,729
Closed -$22.6M 192
2024
Q2
$22.6M Sell
893,729
-189,994
-18% -$4.81M ﹤0.01% 1188
2024
Q1
$33.5M Sell
1,083,723
-76,619
-7% -$2.37M 0.01% 1105
2023
Q4
$46.8M Buy
1,160,342
+664,254
+134% +$26.8M 0.01% 934
2023
Q3
$13.1M Sell
496,088
-266,218
-35% -$7.02M ﹤0.01% 1374
2023
Q2
$13.1M Hold
762,306
﹤0.01% 1431
2023
Q1
$12.6M Sell
762,306
-198,289
-21% -$3.29M ﹤0.01% 1486
2022
Q4
$7.32M Hold
960,595
﹤0.01% 1662
2022
Q3
$9.55M Hold
960,595
﹤0.01% 1557
2022
Q2
$8.72M Sell
960,595
-133,300
-12% -$1.21M ﹤0.01% 1614
2022
Q1
$11.1M Buy
1,093,895
+192,400
+21% +$1.95M ﹤0.01% 1670
2021
Q4
$15M Buy
901,495
+68,263
+8% +$1.14M ﹤0.01% 1604
2021
Q3
$39.1M Buy
833,232
+8,800
+1% +$412K 0.01% 1053
2021
Q2
$50.3M Buy
824,432
+95,603
+13% +$5.83M 0.01% 962
2021
Q1
$44.9M Buy
728,829
+95,845
+15% +$5.9M 0.01% 1037
2020
Q4
$45M Buy
632,984
+59,921
+10% +$4.26M 0.01% 1047
2020
Q3
$21.5M Buy
573,063
+451,246
+370% +$16.9M 0.01% 1379
2020
Q2
$3.97M Hold
121,817
﹤0.01% 1891
2020
Q1
$3.53M Hold
121,817
﹤0.01% 1871
2019
Q4
$4.27M Sell
121,817
-28,183
-19% -$988K ﹤0.01% 1923
2019
Q3
$3.22M Sell
150,000
-150,000
-50% -$3.22M ﹤0.01% 1956
2019
Q2
$8.09M Buy
+300,000
New +$8.09M ﹤0.01% 1859